• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Entrepreneurship 101: Toronto Research Chemicals Business Concept
 

Entrepreneurship 101: Toronto Research Chemicals Business Concept

on

  • 3,429 views

Dr. David Dime tells the story of the growth of Toronto Research Chemicals from a one-man part-time company in 1982 to a world leader in the manufacture of complex organic chemicals for biomedical and ...

Dr. David Dime tells the story of the growth of Toronto Research Chemicals from a one-man part-time company in 1982 to a world leader in the manufacture of complex organic chemicals for biomedical and pharmaceutical research.

An audio file of this presentation can be accessed by going to http://www.marsdd.com/ent101 and clicking on the February 6, 2007 session,
Entrepreneurship 101 - Science and business do mix: The Toronto Research Chemicals story

Statistics

Views

Total Views
3,429
Views on SlideShare
3,419
Embed Views
10

Actions

Likes
0
Downloads
51
Comments
0

2 Embeds 10

http://www.marsdd.com 8
http://www.slideshare.net 2

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Entrepreneurship 101: Toronto Research Chemicals Business Concept Entrepreneurship 101: Toronto Research Chemicals Business Concept Presentation Transcript

    • Our business concept: - custom synthesis of complex organic molecules - market the products and Intermediates - supplement the sales by repackaging of bulk chemicals
    • Metropolitan Toronto Business Journal Dec. 1988
    • Growth
    • Sales
    • Flexibility Personalized attention Technical expertise and scientific innovation
    •  
    •  
    •  
    • www.TRC-Canada.com
    • Carbohydrates and Oligosaccharides Glycosidase Inhibitors Mutagens Protein Kinase C Activators and Inhibitors Nitric Oxide Methanethiosulfonates Nicotine Derivatives Drug Metabolites and research standards
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •